New Pill Technologies
New Pill Technologies: Innovating personalized AI-driven cannabis dosing for consumer health.
Founded
2021New Pill Technologies: Innovating personalized AI-driven cannabis dosing for consumer health.
Founded with a mission to revolutionize consumer health and self-care, New Pill Technologies leverages artificial intelligence to develop personalized cannabis dosing and delivery methods. The company's vision centers on enhancing mental health and overall well-being through innovative, patent-pending technologies. Their platform offers specialized therapeutics, including legal cannabis, psychedelics, and controlled drugs, with real-time tracking of usage, adherence, and efficacy data.
Notable figures in the company include experts in AI and healthcare technology, though specific names are not provided. The startup has attracted significant attention from investors interested in the intersection of technology and mental health. Key achievements include the development of their proprietary AI-driven dosing platform and gaining recognition for their potential impact on psychological and neurological health disorders. Overall, New Pill Technologies is poised to make substantial contributions to the field of mental health therapeutics.
Companies similar to New Pill Technologies include Woven Science, dosist, Gilgamesh Pharmaceuticals and Mindstate Design Labs.
New Pill Technologies was founded in 2021.
New Pill Technologies' headquarters is located in New York City, NY, US.
New Pill Technologies' most recent funding round was for $155k (USD) in July 2021.
As of Jul 22, 2021, New Pill Technologies has disclosed funding of $155k (USD). Undisclosed round amounts are excluded.
New Pill Technologies has 32 employees as of Feb 5, 2024.
Mindstate Design Labs
mindstate.design
